Analytik Jena was founded jointly by Klaus Berka along with Jens Adomat in 1990, shortly after East Germany's peaceful revolution.

Due to the purchase of the laboratory analysis technology of Carl Zeiss Jena GmbH at the end of 1995, the Company's market share in the instrument business increased further.

In the subsequent years, Analytik Jena enforced its growth path due to strategic acquisitions, the expansion of international sales activities and the founding of subsidiaries in Germany and abroad.

Analytik Jena thereby further broadened its atomic spectroscopy portfolio and is among the few suppliers that offer all three core technologies for elemental trace analysis (AAS, ICP-OES, and ICP-MS).

Analytik Jena's business model is structured on the basis of corporate activities in the three operational segments Analytical Instrumentation and Life Science.

With these symbiotically interwoven business units for specialized instruments, Analytik Jena offers products for a technology sector that is both modern and in demand.

It demonstrates the biotechnological competence of Analytik Jena AG and provides a wide product spectrum for automated total, as well as individual solutions[buzzword] for molecular diagnostics.